Gentris’ senior management team is comprised of highly qualified professionals with established and diverse experience in the fields of pharmacogenomics, pharmacology, clinical drug development, laboratory operations, and molecular biology.
L. Scott Clark, Ph.D., Vice President, Global Scientific Operations
Dr. Clark is a pioneer and industry leader in the application of pharmacogenomics to drug development. He has more than 16 years of experience at pharmaceutical and clinical research companies in technology assessment and applications, assay development, laboratory management, and project management. Dr. Clark joined Gentris Corporation from DNA Sciences in September 2001 as laboratory director and was promoted to Chief Scientific Officer in July 2008. He worked at Intek Labs as Clinical Study Director and was instrumental in the success of PPGx, a joint venture between Intek-PPD and Axys Pharmaceuticals.
Dr. Clark earned his Bachelor’s degree in Biology at Hobart College and earned his Ph.D. degree in Cell and Molecular Biology from the University of Vermont where his thesis work focused on human mutation. He completed his post-doctoral training in genetic toxicology at the University of North Carolina and the US EPA.
Reporting to the CEO, Dr. Clark is responsible for the scientific and technological developments and emerging issues germane to the strategy and success of the company.